Maine Medicine Weekly Update - 02/04/2019  (Plain Text Version)

Return to Graphical Version


In this issue:
•  State House Report: MMA Testifies on Gun Violence and Patient Protection Bills
•  MMA Wants Your Feedback: Physician Wellness Survey
•  E-cigarettes Better Than Other Nicotine Replacement Therapies
•  Azar Proposes Shifting Drug Rebates From PBMs to Consumers
•  AMA State Advocacy Summit: 8 Physician Advocacy Wins that Set the Stage for 2019
•  Researchers Say Outpatient Use of Benzodiazepines Increasing
•  MMA Legislative Call Tuesday, February 5th
•  Upcoming Specialty Society Meetings
•  Enrollment Underway for Maine’s Physician Executive Leadership Institute - The Advanced Course - Deadline Extended to February 8, 2019
•  Webinar Presented by Baystate Financial - Sources of Retirement Income - Tuesday, February 12th
•  Identifying Substance Use Early Saves Lives! - SBIRT with Motivational Interviewing Training - 1-day Sessions Offered on March 2 and April 6
•  NAMI Maine’s Beyond the Basics in Suicide Prevention Conference - Friday, April 12, 2019
•  Psychiatric Mental Health NP - Leeds
•  Urgent Care Physician - South Portland, ME
•  PCHC in need of Pediatrician at Multiple Locations!
•  Outpatient Internal Medicine Physician – Bangor, Maine
•  Full-time Board Certified/Board Eligible MD/DO
•  Outpatient Family Medicine - Brunswick, Maine
•  Psychiatric Nurse Practitioner - Nasson Health Care
•  Opportunities at the VA for Volunteer Physicians
•  Volunteer Opportunity with Partners for World Health


Researchers Say Outpatient Use of Benzodiazepines Increasing

Research is showing a concerning increase in the prescription of benzodiazepine medication, with about half of all such prescriptions coming from primary care physicians. This is particularly concerning because benzodiazepines are implicated in a growing number of overdose-related deaths. Addressing prescribing patterns may help curb this growing use.


The NPR (1/25, Chatterjee) “Shots” blog reported, “The percentage of outpatient medical visits that led to a benzodiazepine prescription doubled from 2003 to 2015,” research indicated, with “about half” of “those prescriptions” coming “from primary care physicians.”

Medscape (1/25, Brooks, Subscription Publication) reported the study also found that “benzodiazepines are often coprescribed with opioids and other sedating medications, frequently for conditions other than anxiety and insomnia,” researchers concluded after analyzing data on “more than 386,000 ambulatory care visits from 2003 through 2015.” The findings were published online Jan. 25 in JAMA Network Open.